InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MACALUSO MICHAEL, Chairman & CEO. Insider active across 1 companies, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 6 filings have been logged. The latest transaction was filed on 1 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€34,42668,400 shares@ €0.503316.56% mcap18.0% of flow
Common Stock
SEC:0001415889-22-000257:0·
€34,42668,400 shares@ €0.503316.56% mcap18.0% of flow
Common Stock
SEC:0001415889-22-000257·
€61,45743,470 shares@ €1.413829.56% mcap64.1% of flow
Common Stock
SEC:0001415889-21-005016·
€61,45743,470 shares@ €1.413829.56% mcap32.0% of flow
Common Stock
SEC:0001415889-21-005016:0·
0950,000 shares0
Common Stock
SEC:0001415889-21-004870·
0950,000 shares0
Common Stock
SEC:0001415889-21-004870:0·
6 of 6 declarations
About MACALUSO MICHAEL
Michael Macaluso is the CEO and Director of Ampio Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and oversees daily operations. His expertise in the pharmaceutical sector is essential for guiding the development of new treatments.
